Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug transporter profiling in liver cirrhosis
NCT05741372Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2023
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 1, open-label trial (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area Under the Concentration Time Curve of Rosuvastatin in Plasma Over the Time Interval From 0 to 24 Hours, Maximum Measured Concentration of Rosuvastatin in Plasma at 24 hours and 6 more. Started Sep 2023; status: completed.
Beyond the preview
Go deeper on NCT05741372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05741372.